Open an account

Phibro Animal Health

PAHC · NASDAQ

$38.80−$0.54 (−1.37%)TodayMarket closed ·
Prev close $39.34

About PAHC

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 2,475 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Employees
2,475
Headquarters
Teaneck, New Jersey
Listed
Apr 11, 2014
Sector
Health Care
Industry
Pharmaceuticals
Website
pahc.com

PAHC key statistics

Market cap
1.60B
Price-earnings ratio
16.19
Dividend yield
1.23%
Average volume
211.91K
Volume
153.55K
Open price
$39.34
High today
$39.99
Low today
$38.78
52 Week high
$60.08
52 Week low
$28.25

Phibro Animal Health (PAHC) at a glance

As of Oct 20, 2026, Phibro Animal Health (PAHC) shares are priced at $38.80, giving the company a market cap of 1.60B, a price-to-earnings ratio of 16.19 and a dividend yield of 1.23%.

Today the stock has traded between $38.78 and $39.99. The current price is 0.1% above the day's low and 3.0% below its high.

Volume so far is 153.55K shares, below the average of 211.91K shares a day.

Over the past year Phibro Animal Health has ranged from $28.25 to $60.08, and now sits 33% of the way up that range.

Phibro Animal Health met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q4 FY26 it reported $0.85 per share against an estimate of $0.7273.

The average analyst price target is $41.14, 6.0% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 2 analyst ratings say Buy
  • Buy50.0%
  • Hold50.0%
  • Sell0.0%
Price target · 6 analystsAvg $41.14
Low
$35.35
Now
$38.80
High
$51.45

PAHC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 19.2% on average.

  1. Q1 FY25: reported $0.35 per share against an estimate of $0.2519
  2. Q2 FY25: reported $0.54 per share against an estimate of $0.4335
  3. Q3 FY25: reported $0.63 per share against an estimate of $0.5304
  4. Q4 FY25: reported $0.57 per share against an estimate of $0.5304
  5. Q1 FY26: reported $0.73 per share against an estimate of $0.635
  6. Q2 FY26: reported $0.87 per share against an estimate of $0.6834
  7. Q3 FY26: reported $0.76 per share against an estimate of $0.7273
  8. Q4 FY26: reported $0.85 per share against an estimate of $0.7273

PAHC news

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

  • Phibro Animal Health Q4 2026 Earnings Call: Complete Transcript

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation Declares Quarterly Dividend

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

  • Press releaseBusiness Wire

    Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

Similar companies

Companies in the same industry as Phibro Animal Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.